# Infliximab to Treat Non-Infectious Scleritis

> **NCT00075075** · PHASE1 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 5 (—)

## Conditions studied

- Scleritis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00075075
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-23
- **Primary completion:** —
- **Final completion:** 2007-09-06
- **Target enrollment:** 5 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075075, "Infliximab to Treat Non-Infectious Scleritis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00075075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*